Oncternal Therapeutics, Inc.
ONCT
Revenue
801.00k
▲232.00k▲40.77%
3 Months ChangeAssets
23.86M
▼-5.28M▼-18.13%
3 Months ChangeLiabilities
8.11M
▲1.89M▲30.41%
3 Months ChangeFree Cash Flow
-4.78M
▲3.31M▲40.88%
24 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-09-12
Form 8-K
ID: 0000950170-24-105987
2024-08-08
Form 10-Q
ID: 0000950170-24-094082
2024-08-08
Form 8-K
ID: 0000950170-24-093953
2024-06-21
Form 8-K
ID: 0000950170-24-076218
2024-05-09
Form 10-Q
ID: 0000950170-24-057008
2024-05-09
Form 8-K
ID: 0000950170-24-056882
2024-03-07
Form 8-K
ID: 0000950170-24-027948
2024-01-23
Form 8-K
ID: 0000950170-24-006493
2024-01-05
Form 8-K
ID: 0000950170-24-002434
2023-11-09
Form 10-Q
ID: 0000950170-23-062132